menu

Trauma in the Anticoagulated Patient: Decreasing Morbidity and Mortality in Severe Injuries

Be part of the knowledge.
Register

We’re glad to see you’re enjoying ReachMD…
but how about a more personalized experience?

Register for free

Meet the Experts: Managing Life-Threatening Bleeding in Anticoagulated Patients in the Emergency Department

Trauma in the Anticoagulated Patient: Decreasing Morbidity and Mortality in Severe Injuries

MinuteCE®
ReachMD Healthcare Image
Restart
Resume
Choose a format
Media formats available:
Take 1 Minute Challenge
1 Minute Challenge Completed
1.25 credits
Completing the pre-test is required to access this content.
Completing the pre-survey is required to view this content.
Details
Episodes
Presenters
Documents
Comments
  • Overview

    This program focuses on the management of life-threatening bleeds from a range of specialties: Emergency Medicine, Neurocritical Care, Trauma, and Gastroenterology. A panel of international Emergency Medicine experts will provide perspectives on each of the associated areas of bleeding and relevant clinical cases.

  • Target Audience

    This activity has been designed to meet the educational needs of Emergency Medicine, Neurocritical Care, Trauma, Gastroenterology, and Hematology healthcare professionals and their interdisciplinary team involved in the management of life-threatening bleeds in the presence of an anticoagulant.

  • Learning Objectives

    After participating in this educational activity, participants should be better able to: 

    • Demonstrate the ability to delineate reversal from repletion for life-threatening bleeding in the anticoagulated patient
    • Demonstrate the ability to distinguish treatment implications for intracerebral, cerebellar, subdural, and subarachnoid hemorrhage in the anticoagulated patient
    • Distinguish between gastrointestinal bleeding in the anticoagulated patient, which requires observation in the ICU, versus life-threatening bleeding, which requires specific reversal therapy
    • Review specific reversal and repletion management by the emergency physician for anticoagulated patients with trivial to major trauma
  • Accreditation and Credit Designation Statements

    A logo for a credit company Description automatically generatedIn support of improving patient care, this activity has been planned and implemented by Global Learning Collaborative (GLC) and Total CME, LLC. GLC is jointly accredited by the American Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

    This activity was planned by and for the healthcare team, and learners will receive 1.25 Interprofessional Continuing Education (IPCE) credits for learning and change.

  • Faculty Disclosure of Commercial Relationships

    Disclosure Policy
    In accordance with the ACCME Standards for Integrity and Independence, Global Learning Collaborative (GLC) requires that individuals in a position to control the content of an educational activity disclose all relevant financial relationships with any ineligible company. GLC mitigates all conflicts of interest to ensure independence, objectivity, balance, and scientific rigor in all educational programs. 

    The following faculty have disclosed:

    Richard Body, MB, ChB, PhD, faculty for this educational event, has received consulting fees from Abbott Point of Care, Aptamer Group, Beckman Coulter, Creavo, LumiraDx, Radiometer, Roche Diagnostics, and Siemens Healthineers.

    Susann Järhult, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.

    Natalie Kreitzer, MD, MS,  faculty for this educational event, is a contracted researcher for the HeadSMART program by BrainBox; is a speaker for Alexion, an unaffiliated neurotrauma consultant for the National Football League; and a consultant for Entegrion.    

    Tobias Lindner, MD, faculty for this educational event, has no relevant financial relationships with ineligible companies.

    Martin Möckel, MD, PhD, faculty for this educational event, has received research funding from Roche Diagnostics; and consulting fees from Bayer, BRAHMS GmbH, Roche, AstraZeneca, and Sanofi; and public funding of research.

    Adrian R. Parry-Jones, FRCP, PhD, faculty for this educational event, has received consulting fees from AstraZeneca.

    Vinay Sehgal, MBChB, MRCP, PhD, faculty for this educational event, has received consulting fees from Pentax Medical, Medtronic, and AstraZeneca.

  • Planners and Managers Disclosure List

    The following planners/reviewers/managers have disclosed:

    W. Brian Gibler, MD, FACEP, FACC, FAHA, planner for this educational event, is a board member/shareholder for Entegrion, Inc., and EMCREG-International; and is an advisor for Entegrion, Inc.   

    William Mencia, MD, FACEHP, CHCP, reviewer for this educational event, has no relevant financial relationships with ineligible companies.

    Total CME, LLC., planners, and managers have no relevant commercial relationships to disclose.

    All the relevant financial relationships for these individuals have been mitigated.

  • Disclaimer

    The views and opinions expressed in this educational activity are those of the faculty and do not necessarily represent the views of GLC and Total CME, LLC. This presentation is not intended to define an exclusive course of patient management; the participant should use his/her clinical judgment, knowledge, experience, and diagnostic skills in applying or adopting for professional use any of the information provided herein. Any procedures, medications, or other courses of diagnosis or treatment discussed or suggested in this activity should not be used by clinicians without evaluation of their patient's conditions and possible contraindications or dangers in use, review of any applicable manufacturer’s product information, and comparison with recommendations of other authorities. Links to other sites may be provided as additional sources of information. Once you elect to link to a site outside of MedEd On The Go, you are subject to the terms and conditions of use, including copyright and licensing restrictions, of that site.

    Reproduction Prohibited
    Reproduction of this material is not permitted without written permission from the copyright owner.

  • Provider(s)/Educational Partner(s)

    Jointly provided by Global Learning Collaborative (GLC), EMCREG-International, and Total CME, LLC.

  • Commercial Support

    This activity is supported by an independent educational grant from AstraZeneca.

  • Instructions for Completion

    During the period 10/09/2023 through 10/09/2024, registered participants wishing to receive continuing education credit for this activity must follow these steps:
    1. Read the learning objectives and faculty disclosures.
    2. Answer a pre-program question.
    3. View the program.
    4. Complete the post-test with a score of 100%. 
    5. Complete activity evaluation.
    6. Apply for credit and either bank your credits or print your certificate.

    For Pharmacists: Upon successfully completing the post-test with a score of 100% and the activity evaluation form, transcript information will be sent to the NABP CPE Monitor Service. This may require you to add or update the e-profile ID/date of birth information saved in your account.

  • System Requirements

    • Supported Browsers (2 most recent versions):
      • Google Chrome for Windows, Mac OS, iOS, and Android
      • Apple Safari for Mac OS and iOS
      • Mozilla Firefox for Windows, Mac OS, iOS, and Android
      • Microsoft Edge for Windows
    • Recommended Internet Speed: 5Mbps+

  • Publication Dates

    Release Date:

    Expiration Date:

Facebook Comments

Schedule28 May 2024